Enspectra Health

#PhotonicsWest is off to a great start! We are looking forward to the SPIE Prism Awards on Jan 29 celebrating innovation in photonics & honoring companies that are bringing transformative products to market. @Enspectra Health is delighted to be named a 2025 Prism Award finalist!

Want to learn more about Enspectra's groundbreaking technology which was recently published in Nature Scientific Reports? Check out our blog post here which includes insights into our product development: communities.springernature.com/posts/histolog… ​ ​ The full paper is here: nature.com/articles/s4159…

We're thrilled to be a finalist for the 2025 Prism Award! The @SPIEtweets annual event recognizes transformative photonics innovation. We're honored to be selected in the biomedical category. We look forward to the Jan 29 gala at #PhotonicsWest where the winner will be announced.

Our technology has been published in Scientific Reports, part of the distinguished Nature family. “Our aim is to make the invisible digital by unveiling cellular & molecular information beneath the skin’s surface,” said Gabriel Sanchez, CEO. ​ More here: nature.com/articles/s4159….

Enspectra Health Receives FDA Breakthrough Device Designation for AI-powered Imaging Platform Targeting Skin Cancer.​ prnewswire.com/news-releases/…​ #enspectra #enspectrahealth #digitalhealth #innovation #skincancer #artificialintelligence

Attending ASLMS this week? Catch Dr. Given's talk on the exciting new VIO System, the first new imaging modality cleared in 20+ years by the FDA. ​ To schedule a meeting with Enspectra Health at #aslms2024, send a message to info@enspectrahealth.com. See you in Baltimore!

The Enspectra Health team is on the ground in San Diego! Want to learn more about the revolutionary FDA-cleared VIO System? Drop a note to info@enspectrahealth.com to schedule a live demo. We are excited to connect with our clinical colleagues over the next few days at #AAD2024!

What a celebration! Our amazing village of colleagues, clinical advisors, partners & friends all showed up to celebrate the FDA Clearance of VIO, the first imaging modality cleared in 25 years.​ THANK YOU to our Enspectra family who joined us on this journey. #enspectraproud

Enspectra Announces FDA Clearance of VIO, First Technology to Visualize Skin Cellular Structures in Real-Time. "We are thrilled to receive FDA clearance for the first multiphoton imaging modality to ever be cleared by the FDA." said Gabriel Sanchez, CEO. prn.to/3vorKH5

Another successful American Society for Dermatologic Surgery Annual Meeting!  We're sharing one of our favorite highlights from #ASDS2023 – Dr. Arron presented "A diverse study population for balanced AI analysis of skin type, age, and sex using noninvasive cellular imaging."

"Raise your hand if you, or someone you know, has ever had a skin biopsy" asked Gabriel Sanchez, Enspectra's CEO, at the TCT MedTech Innovation Forum. Nearly every hand in the audience shot up in response to this question. At Enspectra, we are redefining how skin is evaluated.

We have submitted our first 510(k) premarket notification to the U.S. FDA for the VIO System! This hand-held technology enables non-invasive cellular imaging in skin. Achieving this milestone is a major step in the journey to bring this new imaging modality to clinical practice.

Enspectra Health’s Initiative to Advance Predictive Algorithms for Skin Precancers Awarded $2M Grant from the NIH. Learn more at: shorturl.at/fiyB3

Thank you to Dr. Manu Jain for highlighting Enspectra Health's innovative technology in her talk on the future of multimodal imaging at the 25th World Congress of Dermatology last week!​​ #enspectra #enspectrahealth #digitalhealth #innovation #wcd2023 #wcd2023singapore

Thank you to the UCSF Rosenman Institute for inviting Enspectra Health to share an Innovators Alumni update to #healthtech investors, partners, and the 2023 cohort of Rosenman Innovators!​ #enspectra #enspectrahealth #rosenmaninstitute #digitalhealth

Enspectra Health is pioneering the virtual biopsy. Its innovative imaging technology, the VIO™ System, is in a US Pivotal Study to demonstrate the safety & effectiveness in subjects planning to undergo a skin biopsy. There are 16.6 million skin biopsies each year in the US.

Meet Julie who shared her experience with basal cell carcinoma. What began as a tiny mark grew into something more concerning. Julie's story highlights the impact of timely intervention and treatment. Enspectra is dedicated to raising awareness of early detection of skin cancer.

Early detection of skin cancer saves lives. If you see anything unusual on your skin, it is important to get it checked by your dermatologist ASAP. If you are at higher risk for skin cancer, Enspectra would like to remind you to schedule your annual visit. #SkinCancerAwareness

May is Skin Cancer Awareness Month and Enspectra Health supports the @skincancerfoundation initiative to educate people about the dangers of skin cancer. Most cases are curable if diagnosed early enough. Learn what to look for here: skincancer.org/early-detectio….

Enspectra Health is pioneering an innovative, non-invasive modality to evaluate skin lesions. This technology provides clinicians with detailed skin tissue images which hold the potential for informed decision-making leading to earlier diagnosis and better patient outcomes.